July 2023
UHN Research The Krembil is the official newsletter of the Krembil Research Institute, highlighting recent news and awards, innovative research and exciting events happening at Krembil. For more information, visit www.discoverkrembil.ca.

Stories in this month's issue:

Jaideep Bains, PhD
Director, Krembil Research Institute
University Health Network
 

Krembil Research Day 2023

Krembil’s annual Research Day is a unique opportunity for trainees, investigators and staff to come together to network and celebrate research achievements.

This year’s in-person event took place at the MaRS Centre, and hosted approximately 225 trainee researchers, faculty and staff from various disciplines. [Read More]

New Treatment Option

In a landmark development in the fight against Alzheimer disease, the United States Food and Drug Administration (FDA) has granted full approval to the disease-modifying medication lecanemb.  
[Read More]

Making a Mark on Depression

Study identifies markers of treatment response in people with major depressive disorder. [Learn More]
Building Brain Blood Vessels

Study reveals that nucleolin, a brain development protein, becomes reactivated in tumours. [Learn More]
Decoding Roifman Syndrome

Study provides deep insights into why vision impairments occur in Roifman syndrome. [Learn More]
Rehabilitation for Vision Loss

Therapy involving visual tasks with auditory feedback effectively treats form of vision loss. [Learn More]
 

Copyright © 2023, University Health Network, all rights reserved.

If you have any feedback about the newsletter, email us at: www@uhnresearch.ca
To access previous issues, visit the The Krembil archives.